PET imaging of osteosarcoma

W Brenner, KH Bohuslavizki… - Journal of Nuclear …, 2003 - Soc Nuclear Med
During the past decade the clinical value of PET imaging has been investigated for many
different tumors. As knowledge of the advantages and limitations of this modality increased, …

FDG PET in the diagnosis of hilar cholangiocarcinoma

A Fritscher-Ravens, KH Bohuslavizki… - Nuclear medicine …, 2001 - journals.lww.com
Resectional surgery offers a curative intent and a survival benefit for patients with hilar
cholangiocarcinoma, but is associated with high morbidity. Since morphological imaging cannot …

Value of FDG PET in patients with fever of unknown origin

…, R Buchert, KH Bohuslavizki - Nuclear medicine …, 2001 - journals.lww.com
Fever of unknown origin (FUO) is a diagnostic challenge, because the cause of such fever
may be manifold. Studies on the use of positron emission tomography (PET) using 18 F-…

Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan

B Schlüter, KH Bohuslavizki, W Beyer… - Journal of Nuclear …, 2001 - Soc Nuclear Med
FDG PET is increasingly performed in patients with differentiated thyroid cancer who present
with elevated human thyroglobulin (hTG) levels and negative 131 I scan. The aim of this …

FDG PET detection of unknown primary tumors

KH Bohuslavizki, S Klutmann, S Kroger… - The Journal of …, 2000 - search.proquest.com
The management of patients presenting with metastases of unknown primary origin remains
a clinical challenge despite a large variety of imaging modalities. The aim of this study was …

Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography, and endoscopic ultrasonography with …

A Fritscher-Ravens, KH Bohuslavizki, L Brandt… - Chest, 2003 - Elsevier
… Author links open overlay panel Fritscher-Ravens Annette MD a , Bohuslavizki Karl H. MD,
PhD b , Brandt Lars a , Bobrowski Christoph MD c , Lund Christian MD d , Knofel W. Trudo …

18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma

M De Wit, KH Bohuslavizki, R Buchert, D Bumann… - Annals of oncology, 2001 - Elsevier
Purpose The value of 18 FDG-PET to predict the outcome after therapy in Hodgkin's
lymphoma was compared to morphologic staging and ESR Patients and methods A total of 50 …

Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study

…, K Brandt-Mainz, M Dietlein, KH Bohuslavizki… - European journal of …, 2001 - Springer
The aim of this study was to evaluate the clinical use of fluorine-18 fluorodeoxyglucose
positron emission tomography (FDG-PET) in medullary thyroid cancer (MTC) on the basis of …

[PDF][PDF] Quantitative salivary gland scintigraphy.

S Klutmann, KH Bohuslavizki, S Kröger… - Journal of nuclear …, 1999 - Soc Nuclear Med
Objective: Uptake of 99mTc-pertechnetate in salivary glands reflects intact salivary gland
parenchyma. However, no standardized protocol for an accurate quantification of parenchymal …

Comparison of fluorodeoxyglucose positron emission tomography and 'conventional diagnostic procedures' for the detection of distant metastases in breast cancer …

…, S Bachmann, KH Bohuslavizki… - Nuclear medicine …, 2002 - journals.lww.com
The presence of distant metastases is the main prognostic factor in patients with breast
cancer and has a significant influence in the choice of therapy. Therefore, chest X-ray, bone …